Silo Pharma (SILO) Price/OCF Ratio: History & Chart

Silo Pharma, Inc.(SILO)

Biotechnology · Sarasota, FL

$1.42-0.07 (-4.70%)

Delayed quote: Oct 6, 2026, 1:33 PM EDT

About Silo Pharma, Inc.

Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS). The company's approach combines both traditional and psychedelic therapies, with a strong emphasis on innovative formulations and advanced drug delivery systems. Leading its pipeline is SPC-15, an intranasal treatment engineered to address post-traumatic stress disorder (PTSD) and anxiety disorders stemming from stress. Another key development is SP-26, a time-release, ketamine-loaded implant designed to provide relief for fibromyalgia and chronic pain. Furthermore, Silo Pharma is advancing two preclinical programs: SPC-14, an intranasal compound targeting Alzheimer's disease, and SPU-16, a CNS-homing peptide intended for the management of multiple sclerosis (MS). The company's research and development efforts frequently involve collaborations with prominent academic institutions such as Columbia University and the University of Maryland, Baltimore. Founded in 2010, the company adopted its current name, Silo Pharma, Inc., in September 2020, having previously operated as Uppercut Brands, Inc. Silo Pharma is headquartered in Sarasota, Florida.

Sarasota, FL

3 employees

silopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Eric Weisblum

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Silo Pharma, Inc. (SILO)	$1.60M	N/A	N/A	N/A	N/A
PMGC Holdings Inc. (ELAB)vs ›	$1.49M	N/A	N/A	N/A	N/A
Curis, Inc. (CRIS)vs ›	$1.48M	N/A	56.34	56.34	56.34
Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›	$1.51M	N/A	N/A	N/A	N/A
INVO Fertility, Inc. (IVF)vs ›	$1.44M	N/A	7.82	7.82	7.82
NEXGEL, Inc. (NXGL)vs ›	$1.44M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.36M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.34M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.31M	N/A	N/A	N/A	N/A
NewcelX Ltd. (NCEL)vs ›	$1.32M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

Silo Pharma, Inc. (SILO)

$1.60M

N/A

PMGC Holdings Inc. (ELAB)vs ›

$1.49M

N/A

Curis, Inc. (CRIS)vs ›

$1.48M

N/A

56.34

Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs ›

$1.51M

N/A

INVO Fertility, Inc. (IVF)vs ›

$1.44M

N/A

7.82

NEXGEL, Inc. (NXGL)vs ›

$1.44M

N/A

Artelo Biosciences, Inc. (ARTL)vs ›

$1.36M

N/A

Genprex, Inc. (GNPX)vs ›

$1.34M

N/A

Jupiter Neurosciences, Inc. (JUNS)vs ›

$1.31M

N/A

NewcelX Ltd. (NCEL)vs ›

$1.32M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

SILO Price/OCF Ratio Metrics

SILO Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics